NCT02385851View on ClinicalTrials.gov

Comparison of the Pharmacokinetic and Pharmacodynamic Biosimilarity of CHS-1701 (Coherus Pegfilgrastim) With Neulasta® (Pegfilgrastim)

PHASE1CompletedINTERVENTIONAL
Enrollment

116

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
Bioequivalence
Interventions
DRUG

CHS-1701

DRUG

Pegfilgrastim

Trial Locations (1)

78209

ICON, San Antonio

Sponsors
All Listed Sponsors
lead

Coherus Oncology, Inc.

INDUSTRY